Alerts and recalls

Get emails for this topic

Guidance and regulation

• National Institute for Health and Clinical Excellence (NICE) guidelines on dental recall
  • Guidance
  • 24 March 2011
  • Department of Health and Social Care

See more guidance and regulation in this topic

News and communications

• Kimal Procedure Packs containing recalled components: Namic Angiographic Syringe with the risk of syringe disconnection; Namic Manifolds with the risk of foreign particulates. Important guidance for use in urgent procedures where there are no alternatives.
  • 22 May 2026
  • Medicines and Healthcare products Regulatory Agency
  • Medical safety alert
• Field Safety Notices: 11 to 15 May 2026
  • 22 May 2026
  • Medicines and Healthcare products Regulatory Agency
  • Medical safety alert
• Amiodarone: reminder of risks of treatment and need for patient monitoring and supervision
  • 20 May 2026
  • Medicines and Healthcare products Regulatory Agency
  • Drug safety update
• Risk of severe harm from use of incorrect giving (administration) set for blood transfusion (DSI/2026/003)
  • 20 May 2026
  • Medicines and Healthcare products Regulatory Agency
  • Medical safety alert
• Class 4 Medicines Defect Notification: Fresenius Medical Care Deutschland GmbH, balance 2.3% glucose, 1.25 mmol/l calcium, solution for peritoneal dialysis, EL(26)A/24
  • 14 May 2026
  • Medicines and Healthcare products Regulatory Agency
  • Medical safety alert

See more news and communications in this topic

Research and statistics

• Valproate: Paternal exposure to valproate and risk of neurodevelopmental disorders and congenital malformations in offspring
  • 5 September 2024
  • Medicines and Healthcare products Regulatory Agency
  • Research
• Public Assessment Report of the reclassification of Buscopan IBS Relief, Hyoscine Butylbromide 10mg tablets
  • 11 February 2022
  • Medicines and Healthcare products Regulatory Agency
  • Research
• Report of the Commission on Human Medicine’s Expert Working Group on benefit-risk and risk minimisation measures of the yellow fever vaccine
  • 21 November 2019
  • Commission on Human Medicines
  • Independent report

See more research and statistics in this topic

Organisations

• Medicines & Healthcare products
  Regulatory Agency
• Department
  of Health &
  Social Care
• Commission on Human Medicines